PHILADELPHIA — The epidemic of age-related macular degeneration is expected to increase, according to a speaker here.
“By 2040, there will be 288 million people who will be affected, so this is a daunting task for us to look after such patients,” Emily Y. Chew, MD, said during the Irving H. Leopold Lecture at the Wills Eye Conference.
Chew discussed study results from the Age-Related Eye Disease Study (AREDS), AREDS2 and other analyses related to AMD. Results from AREDS2 suggest that the replacement of beta-carotene supplements with lutein and zeaxanthin reduces the risk for